42 results
8-K
EX-10.1
XLO
Xilio Therapeutics Inc
28 Mar 24
Entry into a Material Definitive Agreement
7:55am
Coverage. The Company and each of its subsidiaries are insured by insurers of recognized financial responsibility against such losses and risks … ) the Placement Agent will not have any responsibility with respect to any information, certificates or documentation delivered by or on behalf
8-K
EX-99.1
10ebun7557vi g2w
5 Sep 23
Xilio Therapeutics Announces Promotion of Katarina Luptakova, M.D., to Chief Medical Officer and Scott Coleman, Ph.D., to Chief Development Officer
8:35am
8-K
ck979gxcq
3 Apr 23
Departure of Directors or Certain Officers
4:05pm
S-3
EX-4.4
3fsy0mu9lzq3obnb
9 Nov 22
Shelf registration
4:15pm
S-3
gggljnm3eg365rkw29x
9 Nov 22
Shelf registration
4:15pm
S-3
EX-4.5
zrgjv
9 Nov 22
Shelf registration
4:15pm
S-3
EX-1.2
q6vi3dmp
9 Nov 22
Shelf registration
4:15pm
8-K
dpfoy1nu28 cv
16 Jun 22
Departure of Directors or Certain Officers
7:45am